Correction Notice: Author Degree Misspelling in the Article "Whole-Blood Transfusion From Empiricism to Evidence: A Narrative Review
-
September 1, 2026
September 1, 2026
New research co-led by a Roswell Park Comprehensive Cancer Center leukemia expert highlights a promising investigational treatment approach using the targeted therapy ziftomenib for patients with a difficult-to-treat form of acute myeloid leukemia (AML).